Rimexolone
Clinical data | |
---|---|
AHFS/Drugs.com | Monograph |
MedlinePlus | a606003 |
Pregnancy category |
|
Routes of administration | Eye drops |
ATC code | H02AB12 (WHO) S01BA13 (WHO) |
Identifiers | |
| |
CAS Number | 49697-38-3 |
PubChem (CID) | 5311412 |
IUPHAR/BPS | 7099 |
DrugBank | DB00896 |
ChemSpider | 4470902 |
UNII | O7M2E4264D |
KEGG | D05729 |
ChEMBL | CHEMBL1200617 |
ECHA InfoCard | 100.211.227 |
Chemical and physical data | |
Formula | C24H34O3 |
Molar mass | 370.525 g/mol |
3D model (Jmol) | Interactive image |
| |
| |
(what is this?) (verify) |
Rimexolone is a glucocorticoid steroid used to treat inflammation in the eye.[1] It is marketed as a 1% eye drop suspension under the trade name Vexol by Alcon Laboratories.[2]
References
- ↑ Kavuncu S, Horoz H, Ardagil A, Erbil HH (August 2008). "Rimexolone 1% versus prednisolone acetate in preventing early postoperative inflammation after cataract surgery". Int Ophthalmol. 28 (4): 281–5. doi:10.1007/s10792-007-9131-0. PMID 17762913.
- ↑ Haberfeld, H, ed. (2015). Austria-Codex (in German). Vienna: Österreichischer Apothekerverlag.
This article is issued from Wikipedia - version of the 11/12/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.